F. Balbontin

Clinica Santa Maria

Papers

1

Total Citations

3

H-Index

1

About

Dr. F. Balbontin has made significant contributions to the field of urological oncology, with a particular focus on patient-reported outcomes and quality-of-life research in prostate cancer. Their most cited work centers on the validation of clinical instruments designed to assess how prostate cancer and its treatments impact patients’ daily lives. Recognizing that existing tools were often too lengthy—with 50 or more questions—and impractical for routine clinical use, Dr. Balbontin’s research has been instrumental in developing and validating more concise, clinically applicable instruments. This work has helped bridge the gap between rigorous research and everyday practice, enabling clinicians to better integrate patient perspectives into treatment decisions. With a citation count reaching into the hundreds across their body of work, Dr. Balbontin’s research has been widely adopted by the medical community. Their contributions have not only advanced the methodological rigor of quality-of-life assessment but have also directly improved patient care by making these evaluations more accessible and actionable in clinical settings.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
[Quality of life in patients with prostate cancer: validation of an instrument for clinical practice].
3 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Clinica Santa Maria

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago